Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide

Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide

US Patent 6894024 · Granted May 17, 2005

Estimated economic value: $14,522,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual ACE C-domain/NEP inhibitors2021
Treatment of hibernating myocardium with an exendin peptide2013
Treatment of hibernating myocardium with an exendin peptide2013
Method of performing angioplasty with a GLP-1 molecule2011
Method of performing angioplasty with a GLP-1 molecule2011
Compositions and methods for treating peripheral vascular disease2011
Metabolic intervention with GLP-1 or its biologically active analogues to improv2010
Metabolic intervention with GLP-1 or its biologically active analogues to improv2010
Exendin improves β-cell response in subjects with impaired glucose tolerance2007
Compositions and methods for treating peripheral vascular disease2007
Treatment of acute coronary syndrome with GLP-12006
Treatment of acute coronary syndrome with GLP-12006